Cold Chain Logistics Market Size, Growth & Trends 2034

Komentari · 65 Pogledi

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Cold Chain Logistics market.

Below is a concise, source-backed briefing for the Cold Chain Logistics market in the same style you used previously. I list leading companies with available revenue / deal values where public, then recent developments, drivers, restraints, regional split, emerging trends, top use cases, major challenges, attractive opportunities, and key expansion factors. Citations follow the most important statements.

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Cold Chain Logistics market.

This holistic report presented by the report is also determined to cater to all the market specific information and a take on business analysis and key growth steering best industry practices that optimize million-dollar opportunities amidst staggering competition in Cold Chain Logistics market.

Read complete report at: https://www.thebrainyinsights.com/report/cold-chain-logistics-market-12593


Company references (major players — with available values / financial context)

  • Lineage, Inc. — largest temperature-controlled warehousing operator. Reported ~USD 5.3B revenue (2024) and was the subject of a large 2024 IPO (~USD 4.4B raise reported).

  • Americold (Americold Realty Trust / COLD) — one of the largest public cold-storage REITs. Total revenues ~USD 2.6–2.7B (2023–2024); recent site investments include a ~USD 127M facility purchase in Houston.

  • DHL Supply Chain, Kuehne + Nagel, Maersk, FedEx, UPS — global logistics leaders with cold-chain divisions (often in Top-10 vendor lists). UPS announced acquisitions to expand healthcare/cold-chain (e.g., UPS acquisition of Andlauer Healthcare for USD 1.6B in 2025).

  • NewCold, AGRO Merchants Group, Burris Logistics, VersaCold, Nichirei, Swire Cold Storage, Preferred Freezer Services, U.S. Cold Storage — major regional/niche cold-chain players frequently cited in market reports and vendor rankings.

(Representative vendor lists / rankings available from Market reports and industry sources; vendor inclusion varies by report scope.)


Representative market-size estimates (pick one provider for consistency)

  • global cold-chain market ~USD 228.3B (2024) → USD 372.0B by 2029 (CAGR ~10.3%). 

  • USD 371.1B (2025) → USD 1,611B by 2033 (CAGR ~20.5%) — larger because of broader scope assumptions.

  • publish mid-range estimates in the USD 220–400B (mid-2020s) baseline with multi-billion to trillion upper forecasts depending on segments included (warehousing + transport + services + packaging + pharma cold chain).

Bottom line: published near-term baselines commonly fall in USD ~220–400B (mid-2020s); longer-term forecasts diverge widely depending on scope (infrastructure, devices, IT, pharma cold-chain ramp).


Recent developments

  • Large M&A / strategic deals as general logistics players expand healthcare/cold capabilities (e.g., UPS agreed to buy Andlauer Healthcare for USD 1.6B — 2025). 

  • Major capacity investments by cold-storage operators — Americold’s USD-127M Houston facility purchase (2024/2025) and other investments to add pallet positions and local capacity.

  • Rail & multimodal refrigerated services rollouts in markets such as India (first refrigerated train from Sanand) showing national infrastructure moves to bolster cold transport.


Drivers

  • Rising demand for temperature-sensitive foods (fresh produce, frozen retail), pharmaceuticals & vaccines, and e-commerce grocery delivery. 

  • Regulatory and quality requirements (food safety, pharma cold-chain standards) raising the bar for controlled transport and storage. 

  • Urbanization & retail growth driving need for local refrigerated hubs and faster last-mile cold delivery. 


Restraints

  • High CAPEX for refrigerated warehousing and specialized vehicles, and elevated energy/operating costs.

  • Skilled labour shortage and operational complexity for handling multi-temp SKUs and compliance.

  • Fragmented regional infrastructure (especially in developing markets) — gaps in refrigerated transport corridors and cold storage density.


Regional segmentation analysis

  • North America — leading share (large retail, grocery, pharma demand, mature 3PL services; home to Lineage, Americold).

  • Asia-Pacific — fastest growth (China, India) driven by food safety, retail modernization, pharma and e-commerce; India cold-chain is a major growth market. 

  • Europe — mature infrastructure with strong regulatory focus and growing pharma cold-chain demand. 

  • LATAM / MEA — emerging spend tied to port/temperature-controlled inland transport and trade; heterogeneous maturity by country.


Emerging trends

  • Pharma & clinical-trial logistics specialization (dedicated lanes, qualified storage for biologics & vaccines).

  • Digital monitoring, IoT telemetry & cold-chain visibility (real-time temperature & location tracking, blockchain pilots for provenance). 

  • Sustainability & energy efficiency: electrified reefers, better insulation, renewable-powered warehouses to cut Opex and emissions.

  • Consolidation & vertical integrators (large players buying specialized regional operators and healthcare specialists).


Top use cases

  1. Frozen & chilled retail distribution (supermarkets, quick-service restaurants).

  2. Pharmaceutical cold-chain (biologics, vaccines, clinical supplies) requiring validated temperature control and documentation.

  3. Cold storage for foodservice / manufacturing inputs (meat, dairy, seafood).

  4. E-commerce grocery & last-mile refrigerated delivery.


Major challenges

  • Power reliability & energy costs for refrigerated assets (especially in developing markets).

  • Maintaining chain integrity across multimodal transport (truck, rail, ocean, air), each with handoffs and compliance needs.

  • Balancing utilization vs overbuild — big capital investments can lead to oversupply if demand softens. Recent post-pandemic adjustments (inventory normalization) have impacted volumes.


Attractive opportunities

  • Specialized pharma cold-chain services (qualification, validated storage, controlled distribution) command higher margins.

  • Last-mile refrigerated networks in dense urban markets and micro-fulfillment centers for grocery.

  • Energy-efficient retrofit & brownfield expansion — improving existing warehouses (LED, insulation, advanced controls) to raise margins.

  • Platform services (visibility, SLA-backed managed cold chain) sold as SaaS + Ops to smaller shippers.


Key factors of market expansion

  • E-commerce grocery growth & consumer demand for fresh/frozen foods.

  • Growth in biologics & temperature-sensitive pharmaceuticals (clinical trials, vaccine programs).

  • Investment by global 3PLs and REITs in cold-storage real estate (driving capacity and consolidation).

  • Improvements in cold-chain visibility & reliability enabling more complex, long-distance cold logistics.


Komentari